Fairman Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$870 Hold
10
– – ﹤0.01% 302
2026
Q2
$790 Hold
10
– – ﹤0.01% 306
2026
Q1
$874 Hold
10
– – ﹤0.01% 296
2025
Q4
$975 Sell
10
-10
-50% -$971 ﹤0.01% 304
2025
Q3
$1.92K Hold
20
– – ﹤0.01% 232
2025
Q2
$1.76K Hold
20
– – ﹤0.01% 211
2025
Q1
$1.61K Hold
20
– – ﹤0.01% 208
2024
Q4
$1.61K Sell
20
-16
-44% -$1.38K ﹤0.01% 235
2024
Q3
$3.27K Hold
36
– – ﹤0.01% 230
2024
Q2
$2.86K Hold
36
– – ﹤0.01% 234
2024
Q1
$3.16K Hold
36
– – ﹤0.01% 221
2023
Q4
$2.99K Buy
+36
New +$2.74K ﹤0.01% 223

Other funds holding MDT

Fairman Group's MDT Position: Q3 2026 in Review

Fairman Group held its Medtronic (MDT) position steady in Q3 2026 at 10 shares worth $870. The position accounts for ﹤0.01% of the portfolio, ranked #302.

Fairman Group first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.27K in Q3 2024. 1,135 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Fairman Group held 10 shares of Medtronic worth $870 as of Q3 2026.
  • Fairman Group left its Medtronic share count unchanged in Q3 2026.
  • Medtronic made up ﹤0.01% of Fairman Group's portfolio in Q3 2026, its #302 holding.
  • Fairman Group first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
  • Fairman Group's Medtronic position peaked at $3.27K in Q3 2024.
  • 1,135 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Fairman Group's 13F filing for Q3 2026, filed 26 Oct 2026.